Table 2.
Relationship between clinicopathological characteristics and circUBE4B-173aa expression in ESCC patients.
| Clinicopathological parameters | Number | circUBE4B-173aa expression level | ||
|---|---|---|---|---|
| High | Low | P value | ||
| Sex | ||||
| male | 23 | 13 | 10 | 0.7471 |
| Female | 17 | 11 | 6 | |
| Age | 59.80 ± 9.431 | 64.05 ± 8.918 | 0.1609 | |
| T stagea | 0.1018 | |||
| T1 + T2 | 19 | 9 | 10 | |
| T3 + T4 | 21 | 16 | 5 | |
| N stagea | 0.1748 | |||
| N0 | 15 | 8 | 7 | |
| N1 + N2 + N3 | 25 | 19 | 6 | |
| TNM stagea | 0.0939 | |||
| I + II | 16 | 7 | 9 | |
| III-IV | 24 | 18 | 6 | |
| Tumor size | 0.0312* | |||
| <3 cm | 13 | 5 | 8 | |
| ≥3 cm | 27 | 21 | 6 | |
| Differentiation | 0.0230* | |||
| Moderate + Well | 18 | 7 | 11 | |
| Poor | 22 | 17 | 5 | |
aTumor, node, metastasis stage (TNM stage).
*P < 0.05